Search results for "Particle fraction"

showing 4 items of 4 documents

Force control and powder dispersibility of spray dried particles for inhalation

2009

This study aims towards a deeper understanding of the correlation between particle morphology, cohesion forces, and aerosol performance of spray dried powders for inhalation. Therefore, forces affecting cohesion and dispersion are consid- ered and some novel contact models are introduced to explain the improved powder dispersibility of corrugated particles. Particles with different degrees of corrugation are prepared by spray drying and characterized. Powder dispersibility is measured by positioning a dry powder inhaler in front of the laser diffraction device. The particle sizes of all powders are in the range of x50 ¼ 2.11 � 0.15 mm. The ratio of mass specific surface area Sm to volume sp…

AerosolsDiffractionSpray driedMaterials scienceNebulizers and VaporizersStatic ElectricityTheoretical modelsAdhesivenessPharmaceutical ScienceMineralogyModels TheoreticalAerosolPharmaceutical PreparationsSpecific surface areaSpray dryingAdministration InhalationWettabilityTransition TemperatureParticle SizePowdersComposite materialMicroparticleCrystallizationParticle fractionJournal of Pharmaceutical Sciences
researchProduct

Statistical tools and control of internal lubricant content of inhalation grade HPMC capsules during manufacture

2016

The internal lubricant content (ILC) of inhalation grade HPMC capsules is a key factor to ensure good powder release when the patient inhales a medicine from a dry powder inhaler (DPI). Powder release from capsules has been shown to be influenced by the ILC. The characteristics used to measure this are the emitted dose, fine particle fraction and mass median aerodynamic diameter. In addition the ILC level is critical for capsule shell manufacture because it is an essential part of the process that cannot work without it. An experiment has been applied to the manufacture of inhalation capsules with the required ILC. A full factorial model was used to identify the controlling factors and from…

Dry powder inhaler (DPI)Materials scienceChemistry PharmaceuticalPharmaceutical ScienceNanotechnologyCapsulesOleic Acids02 engineering and technology030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineHypromellose DerivativesAdministration InhalationAerodynamic diameterHPMC capsulesLubricantskin and connective tissue diseasesLubricantsFactorial modelModels StatisticalInhalationDry Powder Inhalers021001 nanoscience & nanotechnologyHypromellose DerivativesDry-powder inhalerbody regionsAerosolizationInternal lubricantLinear models0210 nano-technologyMATEMATICA APLICADABiomedical engineeringParticle fraction
researchProduct

Physicochemical compatibility and stability of nebulizable drug admixtures containing Dornase alfa and tobramycin.

2012

The objective of this in-vitro study was to determine whether admixtures of the inhalation solutions Pulmozyme(®) (Dornase alfa) and either Bramitob(®) or Tobi(®) (both containing Tobramycin) are physicochemically compatible and to analyze the aerodynamic parameters of these admixtures. After mixing, test solutions were stored at room temperature and under ambient light conditions over a period of 24 h. Tobramycin concentrations were determined by using a fluorescence immunoassay. Stability of dornase alfa was determined by size-exclusion high performance liquid chromatography, ultraviolet spectroscopy, sodium dodecyl sulfate polyacrylamide gel electrophoresis and tentacle strong cation-exc…

Pulmonary and Respiratory MedicineTime FactorsDrug StorageHigh-performance liquid chromatographyDrug Incompatibilitychemistry.chemical_compoundDrug StabilityAdministration InhalationmedicineTobramycinGeometric standard deviationDeoxyribonuclease IPharmacology (medical)Sodium dodecyl sulfateParticle SizeAerosolsChromatographyInhalationNebulizers and VaporizersBiochemistry (medical)Osmolar ConcentrationDornase alfaHydrogen-Ion ConcentrationRecombinant ProteinsAnti-Bacterial AgentsDrug CombinationsPharmaceutical SolutionschemistryCompatibility (mechanics)TobramycinFeasibility StudiesParticle fractionmedicine.drugPulmonary pharmacologytherapeutics
researchProduct

Aerosolization Performance of Jet Nebulizers and Biopharmaceutical Aspects

2019

In this work, 13 jet nebulizers, some of which in different configurations, were investigated in order to identify the biopharmaceutical constraints related to the quality attributes of the medicinal products, which affect their safety, efficiency, compliance, and effectiveness. The aerosolization parameters, including the aerosol output, aerosol output rate, mass median aerodynamic diameter, and fine particle fraction, were determined according to the European Standard EN 13544-1, using sodium fluoride as a reference formulation. A comparison between the aerosol output nebulization time and the fine particle fraction displayed a correlation between the aerosol quality and the nebulization …

respirable dose delivery ratePharmaceutical SciencePatient characteristicslcsh:RS1-441030226 pharmacology & pharmacycomplex mixturesArticleNOlcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineAerosol output Aerosol output rate Fine particle fraction Mass median aerodynamic diameter Nebulizers Respirable delivered dose Respirable dose delivery rateAerosolizationaerosol output raterespirable delivered dosemass median aerodynamic diameterDose deliveryJet (fluid)aerosol outputrespiratory systemAerosolNebulizerBiopharmaceutical030228 respiratory systemEnvironmental sciencefine particle fractionnebulizersBiomedical engineeringParticle fractionPharmaceutics
researchProduct